Vasu R. Sah

1.1k citations

19 papers · 749 indexed · h-index 10

Co-authors: Krasimir Vasilev Petr Martínek Hans J. Griesser Robert D. Short Andrew Michelmore Chi P. Ndi Jonas A. Nilsson Lisa M. Nilsson
Topics: Cancer Immunotherapy and Biomarkers (6 papers)Immunotherapy and Immune Responses (6 papers)Ocular Oncology and Treatments (6 papers)
Cited by: Surfaces, Coatings and Films Ophthalmology Immunology
Journals: Nature Communications Nano Letters Cancer Research
Partner nations: Australia United States Sweden

In The Last Decade

Vasu R. Sah

19 papers receiving 742 citations

Peers

Countries citing papers authored by Vasu R. Sah

Since Specialization

Citations

This map shows the geographic impact of Vasu R. Sah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasu R. Sah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasu R. Sah more than expected).

Fields of papers citing papers by Vasu R. Sah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vasu R. Sah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasu R. Sah. The network helps show where Vasu R. Sah may publish in the future.

Co-authorship network of co-authors of Vasu R. Sah

This figure shows the co-authorship network connecting the top 25 collaborators of Vasu R. Sah. A scholar is included among the top collaborators of Vasu R. Sah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vasu R. Sah. Vasu R. Sah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases 2024 ·eLife ·Joakim Karlsson,Vasu R. Sah,Roger Olofsson Bagge,Irina Kuznetsova,(unknown),Samuel Alsén,(unknown),Alka Saxena,Lars Ny,Lisa M. Nilsson,Jonas A. Nilsson	2
2	Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases 2023 ·eLife ·Joakim Karlsson,Vasu R. Sah,Roger Olofsson Bagge,Irina Kuznetsova,(unknown),Samuel Alsén,(unknown),Alka Saxena,Lars Ny,Lisa M. Nilsson,Jonas A. Nilsson	2
3	Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro 2023 ·Frontiers in Cell and Developmental Biology ·(unknown),Peter Larsson,(unknown),Vasu R. Sah,Toshima Z. Parris	6
4	Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy 2023 ·Cancer Research Communications ·Vasu R. Sah,Henrik Jespersen,Joakim Karlsson,Lisa M. Nilsson,Mattias Bergqvist,Iva Johansson,Ana Carneiro,Hildur Helgadóttir,Max Levin,Gustav Ullenhag,Anders Ståhlberg,Roger Olofsson Bagge,Jonas A. Nilsson,Lars Ny	6
5	Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma 2021 ·Melanoma Research ·Vasu R. Sah,Joakim Karlsson,Henrik Jespersen,Mattias F. Lindberg,Lisa M. Nilsson,Lars Ny,Jonas A. Nilsson	15
6	The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma 2021 ·Nature Communications ·Lars Ny,Henrik Jespersen,Joakim Karlsson,Samuel Alsén,Stefan Filges,Charlotta All‐Eriksson,Bengt Åndersson,Ana Carneiro,Hildur Helgadóttir,Max Levin,Ingrid Ljuslinder,Roger Olofsson Bagge,Vasu R. Sah,Ulrika Stierner,Anders Ståhlberg,Gustav Ullenhag,Lisa M. Nilsson,Jonas A. Nilsson	120
7	Molecular profiling of driver events in metastatic uveal melanoma 2020 ·Nature Communications ·Joakim Karlsson,Lisa M. Nilsson,(unknown),Samuel Alsén,Ganesh Vilas Shelke,Vasu R. Sah,(unknown),Ulrika Stierner,Charlotta All‐Eriksson,Berglind O. Einarsdottir,Henrik Jespersen,Lars Ny,Per Lindnér,Erik Larsson,Roger Olofsson Bagge,Jonas A. Nilsson	104
8	Abstract 3751: Inhibition of A2AR by AZD4635 induces anti-tumor immunity alone and in combination with anti-PD-L1 in preclinical models 2018 ·Cancer Research ·Alexandra Borodovsky,Yanjun Wang,Minwei Ye,J.C. Shaw,Kris F. Sachsenmeier,Nanhua Deng,Kelly Goodwin,James Clarke,Richard J. A. Goodwin,Nicole Strittmatter,Carl Hay,Vasu R. Sah,Deborah Lawson,Corinne Reimer,Miles Congreve,Jonathan S. Mason,Fiona H. Marshall,Paul D. Lyne,Richard Woessner	8
9	The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment 2017 ·Journal for ImmunoTherapy of Cancer ·Edmund Poon,Stefanie Mullins,Amanda Watkins,Geoffrey S. Williams,Jens‐Oliver Koopmann,Gianfranco Di Genova,Marie Cumberbatch,Margaret H. Veldman-Jones,Shaun Grosskurth,Vasu R. Sah,Alwin G. Schuller,(unknown),Simon J. Dovedi,Paul D. Smith,Ross Stewart,Robert W. Wilkinson	59
10	Abstract 5580: Preclinical pharmacodynamics and antitumor activity of AZD4635, a novel adenosine 2A receptor inhibitor that reverses adenosine mediated T cell suppression 2017 ·Cancer Research ·Alexandra Borodovsky,Yanjun Wang,Minwei Ye,J.C. Shaw,Kris F. Sachsenmeier,Nanhua Deng,(unknown),Adrian J. Fretland,James Clarke,Richard J. A. Goodwin,Nicole Strittmatter,Carl Hay,Vasu R. Sah,(unknown),Corinne Reimer,Miles Congreve,Jonathan S. Mason,Fiona H. Marshall,Paul D. Lyne,Richard Woessner	19
11	Abstract 3684: Inhibition of STAT3 by antisense oligonucleotide treatment decreases the immune suppressive tumor microenvironment in syngeneic and GEM tumor models 2017 ·Cancer Research ·Rich Woessner,Vasu R. Sah,Patricia McCoon,Shaun Grosskurth,Nanhua Deng,Rachel DuPont,Deborah Lawson,Lourdes Pablo,Corinne Reimer,Marco A. De Velasco,Hirotsugu Uemura,Juliana Candido,Paul D. Lyne	1
12	Toxicology Study of Single-walled Carbon Nanotubes and Reduced Graphene Oxide in Human Sperm 2016 ·Scientific Reports ·Waseem Asghar,Hadi Shafiee,Vanessa Velasco,Vasu R. Sah,Shirui Guo,Rami El Assal,Fatih İnci,(unknown),(unknown),Raymond M. Anchan,George L. Mutter,Mihrimah Ozkan,Cengiz S. Ozkan,Utkan Demirci	46
13	Abstract A94: STAT3 antisense treatment decreases M2 macrophage infiltration and enhances the activity of checkpoint inhibitors in preclinical tumor models 2015 ·Molecular Cancer Therapeutics ·Richard Woessner,Patricia McCoon,Shaun Grosskurth,Paul D. Lyne,Kirsten Bell,Michael P. Collins,Nanhua Deng,Rachel DuPont,Michele Johnstone,Youngsoo Kim,Deborah Lawson,Robert A. MacLeod,Lourdes Pablo,Corinne Reimer,Vasu R. Sah,Margaret H. Veldman-Jones	2
14	Abstract A93: STAT3 inhibition enhances the activity of immune checkpoint inhibitors in murine syngeneic tumor models by creating a more immunogenic tumor microenvironment 2015 ·Cancer Immunology Research ·Rich Woessner,Patricia McCoon,Kirsten Bell,Rachel DuPont,Michael P. Collins,(unknown),(unknown),Lourdes Pablo,Corinne Reimer,Vasu R. Sah,Paul D. Lyne	2
15	Bacteria Inside Semiconductors as Potential Sensor Elements: Biochip Progress 2014 ·Sensors ·Vasu R. Sah,Robert Baier	5
16	Surface Morphology in the Early Stages of Plasma Polymer Film Growth from Amine‐Containing Monomers 2011 ·Plasma Processes and Polymers ·Andrew Michelmore,Petr Martínek,Vasu R. Sah,Robert D. Short,Krasimir Vasilev	69
17	Antibacterial surfaces by adsorptive binding of polyvinyl-sulphonate-stabilized silver nanoparticles 2010 ·Nanotechnology ·Krasimir Vasilev,Vasu R. Sah,Renee V. Goreham,Chi P. Ndi,Robert D. Short,Hans J. Griesser	71
18	Early Stages of Growth of Plasma Polymer Coatings Deposited from Nitrogen‐ and Oxygen‐Containing Monomers 2010 ·Plasma Processes and Polymers ·Krasimir Vasilev,Andrew Michelmore,Petr Martínek,Joseph Chan,Vasu R. Sah,Hans J. Griesser,Robert D. Short	82
19	Tunable Antibacterial Coatings That Support Mammalian Cell Growth 2009 ·Nano Letters ·Krasimir Vasilev,Vasu R. Sah,Karine Anselme,Chi P. Ndi,Mihaela Mateescu,(unknown),Petr Martínek,(unknown),Lydie Ploux,Hans J. Griesser	130

About Vasu R. Sah

Vasu R. Sah is a scholar working on Ophthalmology, Immunology and Physiology, having authored 19 papers that have together received 749 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (6 papers) and Ocular Oncology and Treatments (6 papers). The work is most often cited by research in Surfaces, Coatings and Films (120 citations), Ophthalmology (141 citations) and Immunology (168 citations). Vasu R. Sah has collaborated with scholars based in Australia, United States and Sweden. Frequent co-authors include Krasimir Vasilev, Petr Martínek, Hans J. Griesser, Robert D. Short, Andrew Michelmore, Chi P. Ndi, Jonas A. Nilsson, Lisa M. Nilsson, Henrik Jespersen and Joakim Karlsson. Their work appears in journals such as Nature Communications, Nano Letters and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact